We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biocircuits BIOC
BIOC 0.780+2.0%9:33 AM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Craig Rodkin who wrote (42)7/15/1997 4:00:00 PM
From: Steve Robinett   of 65
Craig, Just guessing but I'd say it's the 2nd-tranche-effect. Without it, they were deadmeat--delisted and gone to the pinks. With it, they live for another year. Combined with the Beckton-Dickenson deal, solving their sales and manufacturing problems so they can pay attention to expanding the test menu, this dog is starting to hunt.
I took a look at some of the back SEC filings. If I've got this right, it appears the 10 investors in the private placement financing deal put in equal portions. Among the 10 are the Pres and a couple of other insiders. That means over the last 4 month, each of them has ponied up about $600,000 to keep BIOC alive. I do like to see insiders putting more money in a company. Especially when they're buying in at about $1 and my cost is 13/16.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext